Foresite Capital Management VI LLC

Reported value$643Mas of Jun 30, 2026

Positions23 8 new, 2 sold out

Top 10 weight82%CGON alone is 26%

FiledAug 1445 days after quarter end

Portfolio · as of Jun 30, 2026

Where the money is

New or addedTrimmedHeld

CGON

ALMS

SPTX

Seaport Therapeutics, Inc.

6.0%New

DNLI

Denali Therapeutics Inc.

5.6%Added

CLDX

Celldex Therapeutics, Inc.

5.1%Added

AGIO

Agios Pharmaceuticals, Inc.

4.5%Added

CRVS

Corvus Pharmaceuticals, Inc.

4.3%

PBLS

Parabilis Medicines, Inc.

4.3%New

GHRS

GH Research PLC

3.9%Added

JBIO

Jade Biosciences, Inc.

3.1%Added

13 others

18.5%

Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.

What changed

Biggest moves since Mar 31, 2026

Filed Aug 14, 2026, compared with the May 15, 2026 filing

add_circleNew

SPTX $38.7M
PBLS $27.3M
BEAM $11.3M
AVBP $10.5M

arrow_upwardAdded

GHRS +198%
CLDX +178%
JBIO +177%
AGIO +50%

arrow_downwardTrimmed

None

remove_circleSold out

Centessa Pharmaceuticals plc $54.2M
OKUR $5.99M